WO2007111993A3 - Polyamine analogs as therapeutic agents for skin diseases - Google Patents
Polyamine analogs as therapeutic agents for skin diseases Download PDFInfo
- Publication number
- WO2007111993A3 WO2007111993A3 PCT/US2007/007226 US2007007226W WO2007111993A3 WO 2007111993 A3 WO2007111993 A3 WO 2007111993A3 US 2007007226 W US2007007226 W US 2007007226W WO 2007111993 A3 WO2007111993 A3 WO 2007111993A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polyamine analogs
- skin diseases
- therapeutic agents
- psoriasis
- dermatitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
This disclosure relates to methods of treating atopic dermatitis, contact dermatitis, psoriasis, and certain other skin diseases using polyamine analogs. Conformationally restricted polyamine analogs are particularly useful in treating atopic dermatitis, contact dermatitis, and psoriasis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78505106P | 2006-03-22 | 2006-03-22 | |
US60/785,051 | 2006-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007111993A2 WO2007111993A2 (en) | 2007-10-04 |
WO2007111993A3 true WO2007111993A3 (en) | 2008-02-28 |
Family
ID=38541675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/007226 WO2007111993A2 (en) | 2006-03-22 | 2007-03-22 | Polyamine analogs as therapeutic agents for skin diseases |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007111993A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103118692A (en) | 2010-04-26 | 2013-05-22 | Atyr医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
CA2797362C (en) | 2010-04-27 | 2020-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
US8993723B2 (en) | 2010-04-28 | 2015-03-31 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases |
CN103097523B (en) | 2010-04-29 | 2016-09-28 | Atyr医药公司 | The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds |
WO2011139907A2 (en) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
CN103140233B (en) | 2010-05-03 | 2017-04-05 | Atyr 医药公司 | Treatment, diagnosis and the discovery of antibody compositions related to the protein fragments of methionyl-tRNA synthetase |
US8961961B2 (en) | 2010-05-03 | 2015-02-24 | a Tyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases |
CA2797977C (en) | 2010-05-03 | 2019-08-20 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
EP2566499B1 (en) | 2010-05-04 | 2017-01-25 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
CN103200953B (en) | 2010-05-14 | 2017-02-15 | Atyr 医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
JP6046607B2 (en) | 2010-05-27 | 2016-12-21 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutaminyl tRNA synthetase |
WO2011153277A2 (en) | 2010-06-01 | 2011-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
EP2593125B1 (en) | 2010-07-12 | 2017-11-01 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
US9029506B2 (en) | 2010-08-25 | 2015-05-12 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases |
US8691750B2 (en) | 2011-05-17 | 2014-04-08 | Axolabs Gmbh | Lipids and compositions for intracellular delivery of biologically active compounds |
US10815276B2 (en) | 2014-05-21 | 2020-10-27 | Entrada Therapeutics, Inc. | Cell penetrating peptides and methods of making and using thereof |
CN106852146B (en) | 2014-05-21 | 2021-08-13 | 恩特拉达治疗学股份有限公司 | Cell penetrating peptides and methods of making and using the same |
EP3185880B1 (en) | 2014-08-27 | 2020-02-12 | Ohio State Innovation Foundation | Improved peptidyl calcineurin inhibitors |
CA3078504A1 (en) | 2017-10-04 | 2019-04-11 | Ohio State Innovation Foundation | Bicyclic peptidyl inhibitors |
WO2019148194A2 (en) | 2018-01-29 | 2019-08-01 | Ohio State Innovation Foundation | Peptidyl inhibitors of calcineurin-nfat interaction |
WO2019165183A1 (en) | 2018-02-22 | 2019-08-29 | Entrada Therapeutics, Inc. | Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy |
US11987647B2 (en) | 2018-05-09 | 2024-05-21 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
KR102167755B1 (en) | 2018-05-23 | 2020-10-19 | 주식회사 큐어바이오 | Fragmented GRS polypeptide, mutants thereof and use thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4112067A (en) * | 1977-02-17 | 1978-09-05 | The Dow Chemical Company | Method for treating poison ivy dermatitis using certain polyamines and polytertiaryamides |
US4160819A (en) * | 1972-12-27 | 1979-07-10 | Cincinnati Milacron, Inc. | Method of inhibiting skin irritation |
US5507321A (en) * | 1993-08-25 | 1996-04-16 | Ykk Corporation | Heald frame for weaving a slide fastener stringer |
US6794545B1 (en) * | 1999-04-30 | 2004-09-21 | Slil Biomedical Corporation | Conformationally restricted polyamine analogs as disease therapies |
-
2007
- 2007-03-22 WO PCT/US2007/007226 patent/WO2007111993A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4160819A (en) * | 1972-12-27 | 1979-07-10 | Cincinnati Milacron, Inc. | Method of inhibiting skin irritation |
US4112067A (en) * | 1977-02-17 | 1978-09-05 | The Dow Chemical Company | Method for treating poison ivy dermatitis using certain polyamines and polytertiaryamides |
US5507321A (en) * | 1993-08-25 | 1996-04-16 | Ykk Corporation | Heald frame for weaving a slide fastener stringer |
US6794545B1 (en) * | 1999-04-30 | 2004-09-21 | Slil Biomedical Corporation | Conformationally restricted polyamine analogs as disease therapies |
Also Published As
Publication number | Publication date |
---|---|
WO2007111993A2 (en) | 2007-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007111993A3 (en) | Polyamine analogs as therapeutic agents for skin diseases | |
WO2010097788A3 (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
WO2009050506A3 (en) | Combination 059 | |
IL205279A0 (en) | Methods of treating urogenital - neurological disorders using modified clostridial toxins | |
WO2006120682A3 (en) | Compositions and methods for treating hyperproliferative epidermal diseases | |
WO2007098089A3 (en) | Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs | |
WO2012062925A3 (en) | Compounds and methods for treating pain | |
WO2010132502A3 (en) | Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers | |
MX2011006381A (en) | Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin. | |
EP1998788A4 (en) | Composition and method for topical treatment of tar-responsive dermatological disorders | |
MY173994A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
WO2010083207A3 (en) | Protein kinase c inhibitors and uses thereof | |
WO2009105774A3 (en) | Amino acid inhibitors of cytochrome p450 | |
WO2010025321A3 (en) | Method for treating multiple sclerosis patients with anti-il2r antibodies | |
WO2010017152A3 (en) | Modulation of toll-like receptor 8 expression by antisense oligonucleotides | |
LT2356109T (en) | Compositions and methods for treating alcohol use disorders, pain and other diseases | |
WO2008096203A3 (en) | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders | |
WO2012154695A3 (en) | Treatment of polycystic disease | |
WO2008033440A3 (en) | Treatment of hyperproliferative diseases with anthraquinones | |
BRPI0506970B8 (en) | alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders | |
WO2007136741A3 (en) | N-desmethyl-doxepin and methods of using the same to treat sleep disorders | |
WO2009150408A3 (en) | Topical antimuscarinic formulations | |
WO2011001111A3 (en) | Use of jasmonic acid to treat oily skin | |
WO2007022642A3 (en) | Anti-inflammatory molecules and their uses | |
WO2010017131A3 (en) | Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07753823 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07753823 Country of ref document: EP Kind code of ref document: A2 |